LYTIR

Company · LGND

Ligand Pharmaceuticals Incorporated

Name as listed on its exchange; filed with the SEC as LIGAND PHARMACEUTICALS INC.

Nasdaq's symbol directory lists LGND on Nasdaq as “Ligand Pharmaceuticals Incorporated - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 15 occasions ($22.5M); 9 planned-sale notices; 3 filings by holders of 5% or more; 4 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $22.5M in total.Jun: Insider sales $2.2MJul: Insider sales $1.6MAug: Insider sales $12.8MSep: Insider sales $342KOct: Insider sales $2.0MNov: Insider sales $3.6MDecJanFebMarAprMayJunJulAugSepOctNov$12.8M
Insider purchases above the line: $0Insider sales below: $22.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Octavio Espinoza, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Aug 12, 2026 sold $9.2M
  2. Andrew Reardon, CLO & Secretary sold on 4 days all under a 10b5-1 plan latest Nov 2, 2026 sold $6.1M
  3. Jason Haas sold on 2 days latest Aug 12, 2026 sold $3.7M
  4. Jason Aryeh sold on 4 days latest Nov 10, 2026 sold $1.7M
  5. Zimmermann Martine sold on 2 days latest Nov 12, 2026 sold $978K
  6. Sabba Stephen L sold on 1 day latest Jun 16, 2026 sold $545K
  7. KOZARICH JOHN W sold on 1 day all under a 10b5-1 plan latest Nov 12, 2026 sold $162K
Every trade (15)
  1. SELLZimmermann Martine sold Nov 12, 2026 2,000 shares filing $636K
  2. SELLKOZARICH JOHN W sold Nov 12, 2026 500 shares 10b5-1 plan (scheduled) filing $162K
  3. SELLJason Aryeh sold Nov 10, 2026 3,000 shares 6 legs combined filing $960K
  4. SELLJason Aryeh sold Nov 4, 2026 282 shares filing $90K
  5. SELLAndrew Reardon, CLO & Secretary sold Nov 2, 2026 5,000 shares 13 legs combined 10b5-1 plan (scheduled) filing $1.6M
  6. SELLJason Aryeh sold Nov 2, 2026 700 shares filing $224K
  7. SELLJason Aryeh sold Oct 30, 2026 1,411 shares 5 legs combined filing $452K
  8. SELLAndrew Reardon, CLO & Secretary sold Oct 2, 2026 5,000 shares 6 legs combined 10b5-1 plan (scheduled) filing $1.5M
  9. SELLZimmermann Martine sold Sep 10, 2026 1,200 shares filing $342K
  10. SELLOctavio Espinoza, Chief Financial Officer sold Aug 12, 2026 31,641 shares 10b5-1 plan (scheduled) filing $9.2M
  11. SELLJason Haas sold Aug 12, 2026 7,138 shares filing $2.1M
  12. SELLAndrew Reardon, CLO & Secretary sold Aug 3, 2026 5,000 shares 10 legs combined 10b5-1 plan (scheduled) filing $1.4M
  13. SELLAndrew Reardon, CLO & Secretary sold Jul 1, 2026 5,000 shares 8 legs combined 10b5-1 plan (scheduled) filing $1.6M
  14. SELLSabba Stephen L sold Jun 16, 2026 2,145 shares filing $545K
  15. SELLJason Haas sold Jun 12, 2026 6,461 shares 2 legs combined filing $1.7M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. MARTINE ZIMMERMANN filed Nov 12, 2026 Director 2,000 shares planned sale date 11/12/2026 filing $636K
  2. KOZARICH JOHN W filed Nov 12, 2026 Director 500 shares planned sale date 11/12/2026 filing $162K
  3. KOZARICH JOHN W filed Nov 12, 2026 Director 500 shares planned sale date 11/11/2026 filing $159K
  4. Aryeh Jason filed Nov 10, 2026 Director 3,000 shares planned sale date 11/10/2026 filing $960K
  5. Aryeh Jason filed Nov 4, 2026 Director 282 shares planned sale date 11/04/2026 filing $90K
  6. Aryeh Jason filed Nov 2, 2026 Director 700 shares planned sale date 11/02/2026 filing $222K
  7. JASON M ARYEH filed Oct 30, 2026 Director 1,209 shares planned sale date 10/30/2026 filing $385K
  8. Aryeh Jason filed Oct 30, 2026 Director 202 shares planned sale date 10/30/2026 filing $65K
  9. MARTINE ZIMMERMANN filed Sep 10, 2026 Director 1,200 shares planned sale date 09/10/2026 filing $342K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. JANUS HENDERSON GROUP Ltd. filed Nov 16, 2026 Schedule 13G/A passive filing 4.6%
  2. Invesco Ltd. filed Nov 10, 2026 Schedule 13G/A passive filing 7.6%
  3. Invesco Ltd. filed Aug 13, 2026 Schedule 13G passive filing 6.1%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase May 29, 2026 reported Jun 8, 2026 one of 103 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Gilbert Cisneros (D-CA31): Purchase Jan 15, 2026 reported Feb 13, 2026 one of 151 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  4. Gilbert Cisneros (D-CA31): Purchase Jan 5, 2026 reported Feb 13, 2026 one of 151 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 29, 2026
  2. Regulation FD disclosure; Other events filing Sep 24, 2026
  3. Regulation FD disclosure filing Sep 22, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.